Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics

Announcing JAM-2: Drug-like antibodies straight from the computer
Technical ReportAnnouncing JAM-2: Drug-like antibodies straight from the computer
Technical ReportNabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics
